Articles tagged with Clinical Research
Researchers found that brief interventions with core physician teams boosted internal coordination, leading to better learning and productivity among trainees. Team coordination with external roles, such as nurses, also enhanced trainee learning and patient stays were shorter.
The Colorectal Cancer Alliance's Project Cure CRC has awarded nearly $5 million in research grants to advance urgent science in colorectal cancer. Recent awardees are working on topics such as radioimmunotherapy, CRISPR technology, and the protein drug ProAgio to better understand and treat this disease.
A clinical trial suggests that tucatinib and trastuzumab may benefit patients with rare bile duct cancer who also have HER2-mutated breast cancer. The treatment combination showed a 46.7% objective response rate in patients with bile duct cancer, compared to 22.2% in the broader patient group.
Using Clinical Design Support Systems (CDSS) can help make maternity services safer for pregnant women, with a meta-analysis of 35 studies showing a 1.69 times higher odds of improved outcomes. The findings support the use of AI and related software tools to improve pregnancy care.
A team of researchers, funded by ARPA-H, aims to create an objective quantitative tool to assess pain in patients. They will use biomarkers such as stress hormones and neurotransmitters to generate a composite panel of markers that can be monitored on a portable device.
A new study from the University of Texas at Arlington suggests that analyzing RNA in urine can show changes in cell types, revealing early signs of cancer and other diseases. This method could help clinicians detect problems earlier when they are more easily treated without invasive procedures.
A Mayo Clinic study found that standing on one leg shows the highest rate of decline with age, indicating balance as a crucial aging indicator. The research suggests people can train their balance without special equipment to maintain independence and well-being.
A new study finds that AI-powered models exhibit similar levels of accuracy as ophthalmologists in identifying infectious keratitis, a leading cause of corneal blindness worldwide. The AI models displayed a sensitivity and specificity of 89.2% and 93.2%, respectively, matching the diagnostic accuracy of human experts.
Researchers used a mouse model to assess the impact of senolytic agents dasatinib and quercetin on pelvic organ prolapse. The study found that D+Q injections did not result in significant differences in prolapse development but reduced cellular senescence markers.
Researchers found that physically fitter patients with metastatic lung cancer live longer and respond better to chemotherapy. The study identified biomarkers in blood plasma that can indicate which patients are most likely to respond to treatment.
A new study found that exposure to higher levels of air pollution as a baby is associated with increased odds of developing a peanut allergy and having it persist throughout childhood. Policies aimed at tackling poor air quality could potentially reduce the development and persistence of peanut allergies, according to researchers.
Dr. Fyodor Urnav proposes a set of initiatives to address the crisis, including pooling patients by syndrome and permitting multiple gene editors in a single Investigational New Drug application. This approach aims to accelerate the development of CRISPR therapies for rare genetic diseases.
Researchers found that WNTinib significantly delayed tumour growth and extended survival in mice with hepatoblastoma cells harboring CTNNB1 mutations. The treatment also showed promise in shrinking tumors in patients' tumor tissue models, with some tumors disappearing completely.
A new AI-powered model has been developed to predict kidney transplant outcomes with high accuracy, offering hope for more efficient organ allocation and improved patient outcomes. The tool, UK-DTOP, outperforms existing methods in predicting outcomes for deceased-donor kidney transplants.
Researchers at Shinshu University developed a simple risk score model to predict successful weaning from mechanical circulatory support. The scoring method uses easily measurable health indicators, such as blood pressure and cardiac output, to categorize patients into five groups with varying success rates.
A recent study found a strong association between floor swabs and COVID-19 cases and outbreaks in two Ontario hospitals. The researchers observed a 15-fold increase in patient cases for every 10-fold increase in viral matter detected on the floor.
A study published in the Journal of the American Medical Association found that methadone is more effective than buprenorphine/naloxone in reducing treatment discontinuation rates among individuals with opioid use disorder. The risk of mortality was low and did not differ significantly between the two medications.
A new study found that transcranial direct current stimulation (tDCS) is a safe and effective treatment for depression when administered at home. Researchers reported significant improvements in depression severity and remission rates compared to a placebo control group.
This article provides practical recommendations for improving ethical oversight of clinical trials in the US. Key findings include enhanced regulatory mechanisms and training programs to ensure compliance with existing regulations.
Researchers found that using valacyclovir for a year can decrease the risk of new or worsening eye disease and prevent vision loss associated with shingles. The study, which enrolled over 500 participants, showed that this treatment reduced the risk of complications by 30%.
The World Medical Association's revised Declaration of Helsinki sets new standards for human participants in medical research, emphasizing informed consent and minimizing risk. The updated principles aim to protect vulnerable populations and promote transparent research practices.
Research suggests that listening to music after surgery can significantly reduce pain levels, anxiety, and heart rate, with patients experiencing a lower need for opioid medication. Music's calming effect may also contribute to faster recovery by easing the transition from waking up after surgery.
Dr. Wai Hong Lo, PhD, has been appointed as the new Editor-in-Chief of ASSAY and Drug Development Technologies, succeeding Dr. Bruce Melancon. Dr. Lo aims to enhance online accessibility, incorporate visuals, and increase social media engagement to reach a broader audience.
The EAT2 study, led by Dr. Ursula White, investigates the lasting health effects of short-term weight gain and loss on fat tissue and overall health. Participants will undergo a dietary intervention program followed by an eight-week weight loss treatment.
A new study suggests that a healthy diet may help keep low-grade prostate cancer from progressing to more aggressive states in men undergoing active surveillance. The research team led by Johns Hopkins Medicine found that a reduced risk of prostate cancer progression is associated with a healthy diet.
Researchers found Edaravone inhibits growth of brain tumor stem cells and prolongs survival in mice with glioblastoma. The study suggests repurposing Edaravone as a potential treatment for this aggressive brain cancer.
A recent study published in eClinicalMedicine found that a combination of amubarvimab and romlusevimab did not reduce the occurrence of long COVID symptoms. The researchers assessed symptom diaries and health-related quality of life questionnaires, but saw no significant difference between treatment and placebo groups.
Glioblastoma, the most malignant primary brain tumour, has an 18-month median survival rate despite treatment. New research from the University of Ottawa suggests a drug used to slow ALS progression may also suppress glioblastoma's self-renewing cancerous stem cells.
A new study has identified novel strains of microbes that have adapted to use limited resources in cities, including those found in Hong Kong's subways and skin. These microbes can metabolize manufactured products, posing health risks if they are pathogenic.
A new study reveals that AI-driven chatbots may perpetuate racial and ethnic biases in pain assessment, leading to further inequalities in healthcare. Researchers found that Black patients were consistently underassessed for their pain compared to white patients, regardless of whether the rater was human or AI.
Researchers found that the oral medication palbociclib stabilized tumor growth and reduced blood tumor marker levels in patients with peritoneal mucinous carcinomatosis, a form of appendix cancer often resistant to standard chemotherapy. The study's findings introduce a first targeted therapy for this rare disease.
Researchers created a single cell atlas of prenatal human skin, providing a molecular recipe for building skin. The study also led to the creation of a mini organ model that grows hair, offering insights into scarless skin repair and potential clinical applications in regenerative medicine.
Researchers at Colorado State University have identified an alternate method to study changes during the DNA replication process in lab settings using genetically modified yeast. This new approach provides a less toxic and quickly reversible alternative to hydroxyurea, allowing for better insight into cell cycle arrest mechanisms.
A study involving 4,500 participants has provided valuable insights into the long-term quality of life of adults with congenital heart disease (CHD). Key findings include a high percentage of participants experiencing comorbidities, arrhythmias, and mood disorders, while quality of life is generally good or better for 84%.
A groundbreaking study has demonstrated the clinical success of a new nanoparticle-based, laser-guided therapy for prostate cancer treatment. The therapy successfully eliminated cancerous cells in 73% of patients after 12 months while preserving key functions and side effects.
A recent clinical trial found that the Nivolumab and Anlotinib combination therapy significantly reduced tumor size in nearly one-third of patients, while most experienced stability in their condition. The treatment also showed improved survival outcomes compared to historical data, with a manageable safety profile.
A University of Michigan-led study found that treatment with either modafinil or cognitive behavioral therapy alone was associated with significant reductions in fatigue over 12 weeks. A combination of both treatments worked as well as each individual treatment but did not result in better fatigue scores.
A study published in the Chinese Medical Journal projects a significant rise in global thyroid cancer burden, with 821,214 new cases and 47,507 related deaths reported worldwide in 2022. The incidence is expected to increase by 44.1% from 2019 to 2030, with women experiencing higher rates than men.
A new article in Journal of Palliative Medicine highlights the growing role of for-profit entities in home health and hospice care, which can compromise care quality and patient welfare. The authors emphasize the need for research and regulatory responses to address these trends and ensure better care for seriously ill older adults.
A recent meta-analysis published in Neurology found that treatment with tenecteplase is associated with a higher likelihood of excellent recovery and reduced disability three months after ischemic stroke compared to alteplase. The study included 11 studies and analyzed data from over 7,800 participants.
A new test mimics allergic reactions in a test tube, showing higher diagnostic accuracy than standard tests for peanut allergy and potentially other allergies. The Hoxb8 Mast Cell Activation Test (Hoxb8 MAT) has been shown to have an exceptionally high diagnostic accuracy of 95% and leads to fewer false negative results.
A new study by Concordia researchers found that one-third of adult childhood cancer survivors experience a severe fear of cancer recurrence, which can cause real distress. The study highlights the need for improved treatment and screening for this understudied population.
A study highlights a significant educational gap in identifying early stages of pressure ulcers in people with dark skin tones, putting them at risk of severe bedsores. Researchers recommend updated clinical guidelines and inclusive education to ensure all nurses can provide equitable care.
A study by Johns Hopkins Medicine found distinct immune 'signatures' in patients who developed adverse events while taking immunotherapy. These signatures, including increases in white blood cells known as Th2 and Th17, predict the development of immune-related adverse events and may be targeted for treatment.
A new Rutgers Health study found that strong leadership and experience are key predictors of team effectiveness, not interdepartmental collaboration. Team diversity did not impact effectiveness in the early planning stage, but was a factor in final report quality.
A large-scale study of children with genetic disorders found that thousands benefited from targeted treatments and support after receiving a genetic diagnosis, with over 20% able to start or adjust therapies. Researchers expect this number to grow as new genetic therapies develop.
Researchers developed gene therapy that automatically converts harmful Omega-6 fatty acids to beneficial Omega-3s, reducing risk of arthritis and other health problems in children with obesity. The treatment also lowered inflammation and improved metabolic health.
Researchers will examine cognitive and psychomotor functions to compare effects of CBD on driving performance between men and women. The five-year study aims to provide a comprehensive understanding of the substance's influence.
Researchers found that certain factors increased the risk of death after sepsis, including advanced age, dementia, heart disease, cancer, and previous hospitalizations. A total of 50.6% of patients with sepsis died within two years, highlighting the need for closer monitoring and follow-up care.
Researchers found a significant increase in the use of naloxone by people without medical training to treat opioid overdoses. From June 2020 to June 2022, EMS reported 24,990 patients receiving naloxone from an untrained bystander before EMS arrived, representing a 43.5% growth.
A novel nanoparticle therapy targets fat absorption in the small intestine, showing significant potential to prevent diet-induced obesity. The treatment involves inhibiting an enzyme called Sterol O-acyltransferase 2 (SOAT2), which plays a critical role in fat absorption.
A new study reveals how chronic stress disrupts the balance of gut microbiota to speed up the progression of colorectal cancer. The research identified a particular bacterial species as a potential therapeutic target, specifically Lactobacillus genus, which is essential for a healthy immune response against cancer.
A new study found that HDL particle quality declines over time in women after menopause, increasing risk of episodic memory loss. Women with smaller, more functional HDL particles are less likely to experience cognitive decline.
A team of scientists, led by Anne Bang, is working to establish clearer connections between genes and their effects on brain function and mental health. They will use high-throughput screening technology to study over 100 genes in brain cells.
A randomised clinical trial shows that integrating physiotherapy and cognitive-behavioural therapy is effective in improving symptoms and physical aspects of the quality of life of patients with functional movement disorders. The study suggests this approach could be cost-effective and opens up new lines of research.
Scientists have developed novel magnetic nanodiscs that can remotely stimulate parts of the brain, potentially treating neurological and psychiatric conditions. The devices were injected into specific brain regions in mice and triggered by a weak electromagnet, demonstrating precise control over neural activity.
The third annual TCT MedTech Innovation Forum will address pressing cardiovascular medicine challenges and unveil disruptive solutions. Visionary leaders from the medtech landscape will convene to explore bold solutions, share pioneering insights, and shape the future of cardiovascular care.
Researchers at Indiana University are developing next-generation ophthalmoscopes to spot early warning signs of diseases like Alzheimer's, diabetes, and heart disease with a simple eye scan. The technology uses machine learning and AI to reduce diagnosis time from days to minutes.
Researchers have identified a key metabolic feature of human tissue-resident NK cells in the lung that enables them to rapidly respond to increased glucose levels. This unique adaptation could be a major target for future therapies in lung diseases, including cancer and infections.
A study found that more than half of the top US physicians who reviewed research for major medical journals received industry payments, with most being for research purposes. The payments may have implications for conflicts of interest and research outcomes, highlighting a need for transparency in the medical publishing system.